66 results
Page 2 of 4
S-3
EX-4.5
shdwt1a01f9q10yszs
30 Mar 22
Shelf registration
8:26am
S-3
EX-4.3
sf7chb0v74qx5 4kbw7
30 Mar 22
Shelf registration
8:26am
8-K
EX-99.1
2rusor0gy s3afdh4
4 Feb 22
Orchard Therapeutics Announces Historic Agreement Making Libmeldy® Available by NHS England for MLD Patients
7:00am
8-K
EX-99.1
rj7bq82tn8lq5kpyg
1 Jul 21
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications
5:02pm
8-K
EX-99.1
49vh1awgnijy
29 Jan 21
Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer
7:03am
8-K
EX-99.1
t8gp jq1cmf3p0mbc
19 Jan 21
Orchard Therapeutics Secures Partnerships to Broaden Access to LibmeldyTM for Eligible Patients in Middle East & Turkey
7:03am
8-K
EX-99.1
h5e6c
21 Dec 20
First gene therapy to receive full EU marketing authorization for eligible MLD patients
7:03am
8-K
EX-99.1
taa0jjmr3j3
8 Dec 20
Other Events
7:03am
8-K
EX-99.1
um51m6v9bi8t
16 Oct 20
Other Events
6:03am
10-Q
e17kr77tn25kzx5m
7 May 20
Quarterly report
4:03pm